Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
MicroRNAs in cancer management and their modulation by dietary agents
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance
Impact of terminal dimethylation on the resistance profile of α- N -heterocyclic thiosemicarbazones
The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration
Mitochondrial superoxide mediates doxorubicin-induced keratinocyte apoptosis through oxidative modification of ERK and Bcl-2 ubiquitination
A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1
Protection of lung epithelial cells from protease-mediated injury by trappin-2 A62L, an engineered inhibitor of neutrophil serine proteases
Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activity
Murine collagen antibody induced arthritis (CAIA) and primary mouse hepatocyte culture as models to study cytochrome P450 suppression
Structure-based development of bacterial nitroreductase against nitrobenzodiazepine-induced hypnosis
Reactivation kinetics of a series of related bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase—Structure–activity relationships